NQAR: Network Quality Aware Routing in Error-Prone Wireless Sensor Networks

We propose a network quality aware routing (NQAR) mechanism to provide an enabling method of the delay-sensitive data delivery over error-prone wireless sensor networks. Unlike the existing routing methods that select routes with the shortest arrival latency or the minimum hop count, the proposed scheme adaptively selects the route based on the network qualities including link errors and collisions with minimum additional complexity. It is designed to avoid the paths with potential noise and collision that may cause many non-deterministic backoffs and retransmissions. We propose a generic framework to select a minimum cost route that takes the packet loss rate and collision history into account. NQAR uses a data centric approach to estimate a single-hop delay based on processing time, propagation delay, packet loss rate, number of backoffs, and the retransmission timeout between two neighboring nodes. This enables a source node to choose the shortest expected end-to-end delay path to send a delay-sensitive data. The experiment results show that NQAR reduces the end-to-end transfer delay up to approximately 50% in comparison with the latency-based directed diffusion and the hop count-based directed diffusion under the error-prone network environments. Moreover, NQAR shows better performance than those routing methods in terms of jitter, reachability, and network lifetime

THE DIFFERENCE OF RESIDENT AND NON-RESIDENT CUSTOMER BASED ON SERVICE QUALITY IN THE RESTAURANT BUSINESS USING CART METHODOLOGY

The food industry contributes to a nation’s economic development in many respects. According to the National Restaurant Association in 2009, there are 945,000 restaurants and sales in the restaurant industry are $566 billion a year, which make up about 13million people or 9% of the U.S. workforce food industry. Both the sales and the number of workforce engaged in the food industry have increased steadily since 1970. In other words, as the United States is experiencing remarkable growth in the restaurant business, there is a great deal of competition for surviving in competitive industry

NQAR: Network Quality Aware Routing in Error-Prone Wireless Sensor Networks

We propose a network quality aware routing (NQAR) mechanism to provide an enabling method of the delay-sensitive data delivery over error-prone wireless sensor networks. Unlike the existing routing methods that select routes with the shortest arrival latency or the minimum hop count, the proposed scheme adaptively selects the route based on the network qualities including link errors and collisions with minimum additional complexity. It is designed to avoid the paths with potential noise and collision that may cause many non-deterministic backoffs and retransmissions. We propose a generic framework to select a minimum cost route that takes the packet loss rate and collision history into account. NQAR uses a data centric approach to estimate a single-hop delay based on processing time, propagation delay, packet loss rate, number of backoffs, and the retransmission timeout between two neighboring nodes. This enables a source node to choose the shortest expected end-to-end delay path to send a delay-sensitive data. The experiment results show that NQAR reduces the end-to-end transfer delay up to approximately 50% in comparison with the latency-based directed diffusion and the hop count-based directed diffusion under the error-prone network environments. Moreover, NQAR shows better performance than those routing methods in terms of jitter, reachability, and network lifetime.Peer Reviewe

Effect of preoperative statin therapy on myocardial protection and morbidity endpoints following off-pump coronary bypass surgery in patients with elevated C-reactive protein level

BACKGROUND: The aim of this study was to investigate the effects of preoperative statin therapy on myocardial protection and morbidity endpoints following off-pump coronary bypass graft surgery (OPCAB) in patients with elevated serum high-sensitivity C-reactive protein (hs-CRP) levels. METHODS: Of the 492 patients who underwent multivessel OPCAB from March 2007 to February 2009, the records of 144 patients whose baseline hs-CRP level > 2 mg/L were reviewed. According to the history of preoperative statin therapy for at least one week, patients were classified as either statin group or control group (72 subjects each). Preoperative and operative characteristics and postoperative data including troponin (Tn)-T level and major morbidity endpoints were obtained and compared. Major morbidity endpoints were defined as permanent stroke, renal dysfunction, hemostatic re-exploration, deep sternal wound infection, and the number of patients requiring prolonged ventilation. RESULTS: Preoperative and operative characteristics were similar between the two groups. There were no significant differences in the incidence of morbidity endpoints between the two groups, except for the number of patients requiring dialysis, which was significantly lower in the statin group (8 vs. 1, P = 0.033). Tn-T level at 24 h after surgery was also significantly lower in the statin group. CONCLUSIONS: In this study, we observed beneficial effects of preoperative statin therapy for at least one week in terms of less myocardial enzyme release and fewer patients requiring dialysis following OPCAB in patients whose preoperative hs-CRP was elevatedope

Cross-genotype protection of live-attenuated vaccine candidate for severe fever with thrombocytopenia syndrome virus in a ferret model

Severe fever with thrombocytopenia syndrome (SFTS) virus (SFTSV) is an emerging tick-borne virus classified within the Banyangvirus genus. SFTS disease has been reported throughout East Asia since 2009 and is characterized by high fever, thrombocytopenia, and leukopenia and has a 12 to 30% case fatality rate. Due to the recent emergence of SFTSV, there has been little time to conduct research into preventative measures aimed at combatting the virus. SFTSV is listed as one of the World Health Organization’s Prioritized Pathogens for research into antiviral therapeutics and vaccine development. Here, we report 2 attenuated recombinant SFTS viruses that induce a humoral immune response in immunized ferrets and confer complete cross-genotype protection to lethal challenge. Animals infected with rHB29NSsP102A or rHB2912aaNSs (both genotype D) had a reduced viral load in both serum and tissues and presented without high fever, thrombocytopenia, or mortality associated with infection. rHB29NSsP102A- or rHB2912aaNSs-immunized animals developed a robust anti-SFTSV immune response against cross-genotype isolates of SFTSV. This immune response was capable of neutralizing live virus in a focus-reduction neutralization test (FRNT) and was 100% protective against a cross-genotype lethal challenge with the CB1/2014 strain of SFTSV (genotype B). Thus, using our midsized, aged ferret infection model, we demonstrate 2 live attenuated vaccine candidates against the emerging pathogen SFTSV

Production of Transgenic Cloned Miniature Pigs with Membrane-bound Human Fas Ligand (FasL) by Somatic Cell Nuclear Transfer

Cell-mediated xenograft rejection, including NK cells and CD8+ CTL, is a major obstacle in successful pig-to-human xenotransplantation. Human CD8+ CTL and NK cells display high cytotoxicity for pig cells, mediated at least in part by the Fas/FasL pathway. To prevent cell-mediated xenocytotoxicity, a membrane-bound form of human FasL (mFasL) was generated as an inhibitor for CTL and NK cell cytotoxicity that could not be cleaved by metalloproteinase to produce putative soluble FasL. We produced two healthy transgenic pigs harboring the mFasL gene via somatic cell nuclear transfer (SCNT). In a cytotoxicity assay using transgenic clonal cell lines and transgenic pig ear cells, the rate of CD8+ CTL-mediated cytotoxicity was significantly reduced in transgenic pig's ear cells compared with that in normal minipig fetal fibroblasts. Our data indicate that grafts of transgenic pigs expressing membrane-bound human FasL control the cellular immune response to xenografts, creating a window of opportunity to facilitate xenograft survival